Advances in the early diagnosis and management of acute myocardial infarction

Emergency Medicine Journal

Volumn 13, Issue 2, 1996, Pages 74-79

  Vincent, Richard ^a  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALTEPLASE; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ATENOLOL; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CREATINE KINASE; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESMOLOL; FIBRINOLYTIC AGENT; LIDOCAINE; MAGNESIUM; METOCLOPRAMIDE; MORPHINE; MYOGLOBIN; NALBUPHINE; NALOXONE; NITRATE; NITROUS OXIDE; OPIATE; OXYGEN; STREPTOKINASE;

ACUTE HEART INFARCTION; ANALGESIA; CORONARY ARTERY DILATATION; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PAIN; REVIEW; ST SEGMENT DEPRESSION; TREATMENT PLANNING; VOMITING;

BIOLOGICAL MARKERS; CREATINE KINASE; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 0029971277     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.13.2.74     Document Type: Article

References (36)

1. Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death and crescendo angina. Br Heart J 1985;53:363-73.
2. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol 1993;22:1228-41.
3. Poole-Wilson PA. The myocardium in ischaemic heart disease. In: Poole-Wilson FA, Sheridan DJ, eds. Athersclerosis in ischaemic heart disease. 2, Myocardial consequences. London: Science Press, 1990:3.1-3.56.
4. Goghlan G. Free radicals and myocardial ischaemia. Cardiol Pract 1991;Nov/Dec-10-17.
5. Davies S. Oxygen free radicals in CVD. Cardiol Pract 1991;Nov/Dec: 18-20.
6. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:537-45.
7. McCance AJ, Thompson PA, Forfar JC. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease. Eur Heart J 1993;14:751-7.
8. Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emision tomography. Circulation 1986;73:951-63.
9. GREAT Group. Feasibility, safety, and efficacy of domicilary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 1992;305:548-53.
10. Adams J, Trent R, Rawles J (on behalf of the GREAT Group). Earliest electrocardiographic evidence of myocardial infarction: implications for thrombolytic treatment. BMJ 1993,307:409-13.
11. Rude RE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3,697 patients. Am J Cardiol 1993;52:936-41.
12. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
13. Altman DG, Bland JM. Diagnostic tests 3: receiver operating characteristic plots. BMJ 1994;309:188.
14. Stevenson RN, Ranjadayalan K, Umachandran V, Timmis A Significance of reciprocal ST depression in acute myocardial infarction: a study of 258 patients treated by thrombolysis. Br Heart J 1993;69:211-4.
15. Krone RJ, Greenberg H, Dwyer EM, Kleiger RE, Boden WH. Long term prognostic significance of ST depression during acute myocardial infarction. J Am Coll Cardiol 1993;22:361-7.
16. The TIMI IIIB Investigators Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave infarction. Circulation 1994;89:1545-56.
17. Kornreich F, Montague TJ, Rautaharju PM. Body surface potential mapping of ST segment changes in acute myocardial infarction. Circulation 1993;87:773-82.
18. McComb JM, McMaster EA, Mackenzie G, Adgey AAJ. Myoglobin and creatine kinase in acute myocardial infarction. Br Heart J 1984;51:189-94.
19. Lee HS, Cross SJ, Garthwait P, et al. Comparison of the value of a novel rapid measurement of myoglobin, creatine kinase, and creatine kinase-MB with the electrocardiogram for the diagnosis of acute myocardial infarction. Br Heart J 1994;71:311-5.
20. Adams JE, Bodor GS, Davila-Roman VG, et al. Trpponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
21. Bakker AJ, Koelemay MJW, Gorgels JPMC, et al. Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction. Eur Heart J 1994;15:45-53.
22. Horowitz RS, Morganroth J. Immediate detection of early high-risk patients with acute myocardial infarction using two-dimensional echocardiographic evaluation of left ventricular wall motion abnormalities. Am Heart J 1982;103:814-22.
23. Hilton TC, Thompson RC, Williams HJ, Saylors R, Fulmer H, Stowers SA. Technetium-99m sestamibi perfusion imaging in the emergency evaluation of chest pain. J Am Coll Cardiol 1994;23:1016-22.
24. Goodman L, Cook EF, Brand DA, et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 1988;318:797-807.
25. Julian DG, Braunwald E, eds. Management of acute myocardiol infarction. London: W B Saunders, 1994.
26. Aghababian RV, ed. Emergency management of cardiovascular disease. Boston: Butterworth-Heinman, 1994.
27. Vincent R, Davidson C, Holmberg S, Norris R, Chamberlain DA. Royal Sussex County Hospital cardiac procedures book. Zeneca Pharma, 1995.
28. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
29. Tan LB, Bryant S, Murray RG, et al Detrimental haemodynamic effects of cyclizine in heart failure. Lancer 1988;i:560-1.
30. Vincent R, Myocardial infarction: thrombolysis after infarction. Prescriber's Journal 1995;35:140-8.
31. Vincent R. Pre-hospital management. In: Julian DG, Braunwald E, eds. Management of acute myocardial infarction. London: W.B.Saunders, 1994:1-28.
32. Elliott JM, Cross DB, Cederholm-Williams SA, White HD. Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy. Am J Cardiol 1993;71:640-5.
33. Yusuf S, Teo K, Woods K. Intravenous magnesium in acute myocardial infarction. Circulation 1993;87:2043-6.
34. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta blockade started early in acute myocardial infarction. Lancet 1988;i:921-3.
35. Turlapary P, Laddu A, Shrinivas Murthy V, Singh B, Lee R. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings. Am Heart J 1987;114:866-85.
36. Cleland JGF. ACE inhibitors for myocardial infarction: how should they be used? Eur Heart J 1995;16:153-9.